RxDoctor Payments Data

Alyssa Lipcsey, PA

Medical · East Norriton, PANPI 1932702321

Payments from drug & device makers

$3,019in general payments, 2019–2025

Across 88 payments — averaging $34.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$519
  • Scilex Pharmaceuticals Inc.$441
  • Vertos Medical, Inc.$302
  • Averitas Pharma Inc.$301
  • Amgen$245
  • Tersera Therapeutics LLC$199
  • plus $1K from 15 others

What the payments were for

  • Travel & lodging$1846%
  • Food & beverage$2,78992%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,019 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$29,740
Medicare patients
60
Services billed
1,650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PercocetOxycodone Hcl/Acetaminophen11$60,280
BelbucaBuprenorphine Hcl28$25,999
Xtampza ErOxycodone Myristate22$18,016
ZtlidoLidocaine14$14,015
Lidocaine68$7,411
MovantikNaloxegol Oxalate16$6,738
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen231$6,673
Oxycodone Hcl205$4,304
Buprenorphine18$4,188
Fentanyl33$4,000
Gabapentin201$2,870
Pregabalin157$2,604
Tizanidine Hcl100$2,250
Morphine Sulfate ErMorphine Sulfate74$2,098
Tramadol Hcl65$1,647

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$67$44,01450 claims
Scilex Pharmaceuticals Inc.Ztlido$441$14,01514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,594 medical providers in Pennsylvania.

Other medical in East Norriton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →